Weight Watchers

What Weight Watchers does

Weight Watchers (WW International, Inc.) is a New York-headquartered, NASDAQ-listed (ticker WW) digital health and weight management company founded in 1963, operating with 1,001-5,000 employees and a direct-to-consumer subscription model that historically served tens of millions of members. The platform combines the proprietary Points-based nutrition tracking program with mobile apps (iOS/Android), AI-powered features (AI Body Scanner via Prism Labs and Weight Health Score), workshop-based coaching and community support, and an affiliated medical group (WW Clinic Entities) that provides telehealth GLP-1 prescriptions through the Med+ product. Recent product surface additions include Core/Core+ subscription tiers ($10-$20/month), a menopause program with Queen Latifah as spokesperson, hormone replacement therapy via telehealth, a diabetes-tailored plan integrated with Abbott FreeStyle Libre 2 CGM, and an employer-sponsored GLP-1 program (RxFlexFund).

The business model is dominated by recurring consumer subscriptions across Core, Core+, and Med+ tiers, complemented by workshop fees, employer wellness contracts, and affiliate commission revenue ($10 per qualifying subscription through the Impact platform). The company distributes through self-serve digital channels, partner telehealth platforms (Ro, LifeMD), pharmacy fulfillment (Amazon Pharmacy), grocery integrations (Instacart, Farmer's Fridge), and channel partnerships with Novo Nordisk (Wegovy subscription) and Eli Lilly (Foundayo oral GLP-1), with international operations across the US, Canada, UK, Australia, and New Zealand. Pricing ranges from $10/month for Core to $149-$329/month for medication-inclusive Med+ and Wegovy packages.

In May 2025 Weight Watchers filed Chapter 11 bankruptcy to restructure approximately $1.15 billion in debt amid declining traditional subscriptions driven by GLP-1 competition (Ozempic, Mounjaro), emerging in July 2025 with noteholder debt-for-equity exchange reducing debt by over 70%. The post-bankruptcy strategy is a pivot toward integrating GLP-1 prescribing with behavioral coaching and outcomes tools, evidenced by Med+ clinical subscription growth of 35.3% YoY in Q3 2025, a December 2025 rebrand and platform relaunch, the Peoplehood acquisition bringing Julie Rice as Chief Experience Officer, and the CMS ACCESS Model 10-year award for digital chronic disease management. Q4 2025 showed a net loss of $6 million with revenue exceeding internal guidance, and a CEO transition occurred in March 2026 with an Office of the CEO structure while a permanent successor is sought.

Name

Weight Watchers

Legal name

WW International, Inc.

Website

https://weightwatchers.com

Company type

Public

Founded year

1963

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Weight Watchers (WW International) is a publicly traded digital weight-health platform combining the proprietary Points nutrition program, mobile apps, telehealth-based GLP-1 prescriptions (Med+), coaching workshops, and employer wellness programs, serving tens of millions of consumer and employer members across the US, Canada, UK, Australia, and New Zealand.

Ownership category

akta.pro rank

Product category

Weight Management Services

NAICS

Diet and Weight Reducing Centers (812191), Convenience Retailers (445131)

SIC

Services-Membership Sports & Recreation Clubs (7997)

akta.pro primary industry

Weight Loss Coaching (Non-Clinical) (HSADAFAB)

akta.pro secondary industry

General Nutrition Coaching (HSADAFAA)

Keywords

• Weight management programs
• Clinical weight loss
• GLP-1 medication support
• Nutrition tracking software
• Telehealth weight loss

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Others

Revenue model

1. Subscription Revenue (Core Programs): Traditional subscription model providing access to the Points Program, coaching, workshops, and digital tools. Includes Core, Core+, and Core+ Menopause subscription tiers at various price points
2. Clinical Subscriptions (Med+): Medical subscription service providing GLP-1 medication prescriptions, clinical consultations, insurance coordination, and behavioral support. Grew 35.3% year-over-year to $26 million in Q3 2025
3. GLP-1 Medication Delivery: Revenue from facilitating access to GLP-1 medications through Med+ program, including oral medications like Eli Lilly's Foundayo at $149/month for self-pay and partnerships with Novo Nordisk for Wegovy
4. Workshop Fees: Revenue from in-person and virtual workshop sessions led by coaches, available as add-on to membership
5. Affiliate Commissions: Commission-based revenue through Impact affiliate program, paying $10 per qualifying subscription to U.S.-based affiliates
6. Employer Wellness Programs (RxFlexFund): Employer-sponsored program providing GLP-1 coverage with behavioral and clinical support, integrating direct manufacturer pricing and flexible employer subsidies

Pricing tiers

Go-to-market motion3 records

Distribution channels10 records

Marketing channels7 records

Core offering

Weight Watchers (WW International, Inc.) operates an integrated weight health platform that combines the proprietary Points-based nutrition tracking program with digital coaching tools, telehealth clinical services (WeightWatchers Clinic), and access to FDA-approved GLP-1 weight-loss medications. The platform serves individual consumers through tiered subscriptions (Core, Core+, Med+) and provides specialized tracks for menopause, diabetes, and employer-sponsored wellness programs.

Product overview

Weight Watchers (WW International, Inc.) operates as a multi-tiered platform offering integrated weight health solutions combining behavioral support, clinical care, and medication services. The core portfolio includes: the Points-based Core Program for behavioral weight management; Core+ premium subscription adding workshops and specialized tracks; Med+ clinical program providing access to GLP-1 medications through affiliated medical groups; the GLP-1 Success Program as behavioral companion for medication users; and the Diabetes-Tailored Plan with Abbott CGM integration. Recent additions include menopause support, hormone replacement therapy, and the AI-powered Body Scanner and Weight Health Score tools. The platform also includes employer solutions (RxFlexFund) and an affiliate program. The company emerged from Chapter 11 bankruptcy in July 2025 and completed a major rebranding in December 2025 to position itself as a comprehensive weight health platform for the GLP-1 era.

Differentiator

Problem solved

Functional benefit

Brands

• Core Program: The essential weight-loss toolkit featuring the Points Program in an easy-to-use app
• Core+ Program
• Med+
• GLP-1 Success Program
• Points Program
• ZeroPoint Foods

Products and services

• Core Program The foundational weight-loss subscription offering the Points Program with nutrition tracking, behavior change tools, and app access for building healthy habits, targeting individual consumers seeking sustainable weight management.
• Core+ Premium subscription tier at $20/month offering personalized weight loss support including nutrition guidance, habit-building tools, 400+ expert-led workshops, and specialized tracks for menopause and GLP-1 users.
• Med+ Clinical care program providing access to GLP-1 and other FDA-approved weight-loss medications through board-certified clinicians at affiliated WeightWatchers Clinic medical groups, with complimentary GLP-1 Success Program access including dosage tracking and side-effect support.
• RxFlexFund Employer-sponsored program providing access to GLP-1 medications with behavioral and clinical support, integrating direct manufacturer pricing and flexible employer subsidies for corporate wellness benefits.
• WW Diabetes-Tailored Plan Specialized program integrating with Abbott FreeStyle Libre 2 continuous glucose monitoring system, allowing users with diabetes or prediabetes to track glucose levels alongside diet and activity data.
• Core+ Menopause Specialized track within Core+ offering targeted support for women experiencing menopause, with Queen Latifah as spokesperson for hormone-related weight changes and symptom management.
• Workshops Coach-led group sessions available in-person and virtually, providing accountability and support. Members who attend Workshops lose two times more weight than those who DIY.
• Hormone Replacement Therapy (HRT) Telehealth service expanding into hormone replacement therapy as treatment moves toward becoming standard of care for menopause, offered through the affiliated WeightWatchers Clinic medical groups.
• WW Affiliate Program Commission-based affiliate program through Impact platform, paying $10 per qualifying subscription to U.S.-based partners who drive traffic to WW.com.

Quantifiable outcome

• Members lose average of 7.4 lbs within first four weeks of starting GLP-1 treatment
• +5 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Eli LillycoreChannel Partner/ Reseller/ Distributor · 9 April 2026WeightWatchers announced offering Eli Lilly's FDA-approved oral GLP-1, Foundayo®, through its Med+ program. The program includes clinical support, behavioral tools, and pricing starting at $149/month for self-pay members. This expansion reflects the company's focus on comprehensive care in the GLP-1 era and partnership with Lilly for pharmaceutical options.
• Novo NordiskcoreChannel Partner/ Reseller/ Distributor · 31 March 2026Novo Nordisk launched first and only multi-month subscription program for FDA-approved Wegovy® through select telehealth providers including WeightWatchers. The program offers eligible self-pay patients lower predictable monthly pricing ($249-$329/month) with savings up to $1,200/year through 3-month to 12-month subscription terms. WeightWatchers serves as a distribution channel for Novo Nordisk's GLP-1 medications.
• Farmer's FridgeminorGTM or Marketing Partner · 27 March 2026Farmer's Fridge and WeightWatchers launched a partnership for National Nutrition Month featuring six WeightWatchers-curated menu items across Farmer's Fridge's network of over 1,800 smart refrigerators deployed in airports, hospitals, offices, universities and rest areas across the U.S. New customers receive 50% off first purchase. Collaboration highlights automated retail as distribution channel for health-conscious consumers.
• CheqUp (UK)minorChannel Partner/ Reseller/ Distributor · 20 March 2026WeightWatchers partnered with CheqUp, a provider of anti-obesity medication, in the UK market to focus on weight-loss drugs while moving away from traditional dieting approach. The partnership supports the growing use of GLP-1 medications in the UK market.
• Amazon PharmacycoreChannel Partner/ Reseller/ Distributor · 20 October 2025WeightWatchers announced collaboration with Amazon Pharmacy to improve access and delivery of weight management medications for members. The partnership offers real-time medication availability, automatic savings, and fast home delivery leveraging Amazon's logistics infrastructure. Integration provides benefits like faster delivery and automatic discounts for GLP-1 medications including Wegovy and Zepbound.
• Novo Nordisk (Expanded Collaboration)coreChannel Partner/ Reseller/ Distributor · 1 July 2025WeightWatchers and Novo Nordisk expanded collaboration to improve medication access through a trusted, holistic model of care. The expanded partnership builds on existing collaboration to provide members with better access to obesity medications combined with behavioral support services.

Scale indicators11 records

Recent moves12 records

Expansion highlights6 records

Emerging players

• Omada Health: Public digital chronic condition management platform (NASDAQ: OMDA) targeting prediabetes, diabetes, and hypertension through employer/payer channels. Competes with WeightWatchers' Diabetes-Tailored Plan and RxFlexFund employer programs.
• Virta Health: Digital health platform for type 2 diabetes reversal and prediabetes using nutrition-based intervention. Comparable to WeightWatchers Diabetes-Tailored Plan with similar prediabetes effectiveness claims and employer channel focus.

Direct peers

• Jenny Craig: Traditional meal-based weight loss program offering coaching and food delivery, historically a direct competitor to WeightWatchers' in-person workshop model. Same target consumer segment with comparable subscription pricing.
• Ro: Direct-to-consumer telehealth platform offering GLP-1 medications (Wegovy) with same distribution partnership with Novo Nordisk that WeightWatchers holds. Competes head-to-head with Med+ for GLP-1 patients seeking online clinical care.
• MyFitnessPal: Leading nutrition tracking app with points-based food database similar to WeightWatchers Points® Program. Competes for the same food-tracking and calorie-counting consumer behavior that historically drove WeightWatchers' Core subscriptions.
• Nutrisystem: Pre-packaged meal-based weight loss program with coaching and community. Direct competitor in the consumer weight loss subscription market historically competing with WeightWatchers' behavioral approach.
• Noom: Digital psychology-based weight loss coaching app with similar Points-like food tracking and coaching model. Direct competitor to WeightWatchers' behavioral Core/Core+ programs targeting the same consumer weight-loss segment.
• LifeMD: Telehealth provider offering GLP-1 weight loss medications with same Novo Nordisk Wegovy distribution partnership as WeightWatchers. Direct competitor in Med+ market with similar subscription model and pricing.
• Hims & Hers Health: Public telehealth platform (NYSE: HIMS) that has expanded into weight loss category with GLP-1 offerings. Competes directly with WeightWatchers Med+ in the consumer-facing virtual care and weight management market.

Broad incumbents

• Teladoc Health: Large public telehealth incumbent (NYSE: TDOC) offering virtual care including weight management through its chronic care platform. Broader portfolio competes with WeightWatchers Clinic for enterprise telehealth contracts and chronic condition management.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ww_uk
• YouTubeyoutube.com/user/WeightWatchers
• Facebookfacebook.com/weightwatchers
• LinkedInlinkedin.com/company/weight-watchers
• Instagraminstagram.com/weightwatchers
• TikToktiktok.com/@weightwatchers

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Weight Watchers